MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisture and light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Molipaxin 150mg tablets (Zentiva Pharma UK Ltd) and Trazodone 150mg tablets (Rivopharm (UK) Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Molipaxin 50mg capsules (Zentiva Pharma UK Ltd) and Trazodone 50mg capsules (Rivopharm (UK) Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac 135mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Gabapentin 300mg capsules (Accord Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Gabapentin 100mg capsules (Accord Healthcare Ltd).

Stability Notes

Store in tightly closed containers.

Provenance

This compatibility recommendation is derived from Crestor 5mg tablets (AstraZeneca UK Ltd).

Stability Notes

Store in tightly closed containers.

Provenance

This compatibility recommendation is derived from Crestor 10mg tablets (AstraZeneca UK Ltd).

Stability Notes

Store in tightly closed containers.

Provenance

This compatibility recommendation is derived from Crestor 20mg tablets (AstraZeneca UK Ltd).

Stability Notes

Store in tightly closed containers.

Provenance

This compatibility recommendation is derived from Crestor 40mg tablets (AstraZeneca UK Ltd).

Stability Notes

Store in well-filled airtight containers, protect from light.

Provenance

This compatibility recommendation is derived from Fultium-D3 800unit capsules (Internis Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.